AXSOME THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
AXSOME THERAPEUTICS, INC. (AXSM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 302.56 thousand shares for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-06.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2023-11-06
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-09-30 was 75.38K shares, a 57.54% decline year-over-year.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-06-30 was 139.49K shares, a 215.32% increase year-over-year.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-03-31 was 87.69K shares, a 30.61% increase year-over-year.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-12-31 was 29.01K shares, a 74.63% decline year-over-year.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 317.94K shares, a 2.24% decline from fiscal 2021.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 325.23K shares, a 56.64% increase from fiscal 2020.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 207.63K shares, a 272.31% increase from fiscal 2019.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 55.77K shares, a 82.88% decline from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2023-09-30 | 75.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 214.87K shares derived: sum of 2 quarters · filed 2023-11-06 | 302.56K shares 10-Q · filed 2023-11-06 | 331.58K shares derived: sum of 4 quarters · filed 2023-11-06 |
| 2023-06-30 | 139.49K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 227.18K shares 10-Q · filed 2023-08-07 | 256.20K shares derived: sum of 3 quarters · filed 2023-08-07 | 433.75K shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 87.69K shares 10-Q · filed 2023-05-09 | 116.71K shares derived: sum of 2 quarters · filed 2023-05-09 | 294.26K shares derived: sum of 3 quarters · filed 2023-05-09 | 338.50K shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 29.01K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 206.57K shares derived: sum of 2 quarters · filed 2023-02-28 | 250.80K shares derived: sum of 3 quarters · filed 2023-02-28 | 317.94K shares 10-K · filed 2023-02-28 |
| 2022-09-30 | 177.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | 221.79K shares derived: sum of 2 quarters · filed 2022-11-07 | 288.93K shares 10-Q · filed 2022-11-07 | 403.30K shares derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-06-30 | 44.24K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 111.38K shares 10-Q · filed 2022-08-09 | 225.75K shares derived: sum of 3 quarters · filed 2022-08-09 | 380.88K shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 67.14K shares 10-Q · filed 2022-05-02 | 181.51K shares derived: sum of 2 quarters · filed 2022-05-02 | 336.64K shares derived: sum of 3 quarters · filed 2022-05-02 | 366.52K shares derived: sum of 4 quarters · filed 2022-05-02 |
| 2021-12-31 | 114.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 269.50K shares derived: sum of 2 quarters · filed 2022-03-01 | 299.38K shares derived: sum of 3 quarters · filed 2022-03-01 | 325.23K shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 155.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 185.01K shares derived: sum of 2 quarters · filed 2021-11-08 | 210.85K shares 10-Q · filed 2021-11-08 | 350.84K shares derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-06-30 | 29.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 55.73K shares 10-Q · filed 2021-08-09 | 195.71K shares derived: sum of 3 quarters · filed 2021-08-09 | 234.99K shares derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | 25.84K shares 10-Q · filed 2021-05-10 | 165.83K shares derived: sum of 2 quarters · filed 2021-05-10 | 205.11K shares derived: sum of 3 quarters · filed 2021-05-10 | 231.13K shares derived: sum of 4 quarters · filed 2021-05-10 |
| 2020-12-31 | 139.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 179.27K shares derived: sum of 2 quarters · filed 2021-03-01 | 205.28K shares derived: sum of 3 quarters · filed 2021-03-01 | 207.63K shares 10-K · filed 2021-03-01 |
| 2020-09-30 | 39.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 65.30K shares derived: sum of 2 quarters · filed 2020-11-05 | 67.64K shares 10-Q · filed 2020-11-05 | 70.14K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 26.02K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 28.36K shares 10-Q · filed 2020-08-10 | 30.86K shares derived: sum of 3 quarters · filed 2020-08-10 | 58.00K shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | 2.34K shares 10-Q · filed 2020-05-11 | 4.84K shares derived: sum of 2 quarters · filed 2020-05-11 | 31.98K shares derived: sum of 3 quarters · filed 2020-05-11 | 40.37K shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | 2.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 29.64K shares derived: sum of 2 quarters · filed 2020-03-12 | 38.02K shares derived: sum of 3 quarters · filed 2020-03-12 | 55.77K shares 10-K · filed 2020-03-12 |
| 2019-09-30 | 27.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 35.52K shares derived: sum of 2 quarters · filed 2019-11-07 | 53.27K shares 10-Q · filed 2019-11-07 | 71.18K shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | 8.39K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 26.13K shares 10-Q · filed 2019-08-08 | 44.04K shares derived: sum of 3 quarters · filed 2019-08-08 | 193.25K shares derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | 17.74K shares 10-Q · filed 2019-05-09 | 35.65K shares derived: sum of 2 quarters · filed 2019-05-09 | 184.87K shares derived: sum of 3 quarters · filed 2019-05-09 | 337.30K shares derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-12-31 | 17.91K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | 167.12K shares derived: sum of 2 quarters · filed 2019-03-15 | 319.56K shares derived: sum of 3 quarters · filed 2019-03-15 | 325.83K shares 10-K · filed 2019-03-15 |
| 2018-09-30 | 149.21K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 301.65K shares derived: sum of 2 quarters · filed 2018-11-09 | 307.93K shares 10-Q · filed 2018-11-09 | 310.01K shares derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-06-30 | 152.44K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 158.71K shares 10-Q · filed 2018-08-08 | 160.80K shares derived: sum of 3 quarters · filed 2018-08-08 | 215.65K shares derived: sum of 4 quarters · filed 2018-08-08 |
| 2018-03-31 | 6.28K shares 10-Q · filed 2018-05-08 | 8.37K shares derived: sum of 2 quarters · filed 2018-05-08 | 63.21K shares derived: sum of 3 quarters · filed 2018-05-08 | 65.55K shares derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | 2.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 56.94K shares derived: sum of 2 quarters · filed 2018-03-07 | 59.28K shares derived: sum of 3 quarters · filed 2018-03-07 | 101.50K shares 10-K · filed 2018-03-07 |
| 2017-09-30 | 54.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 57.19K shares derived: sum of 2 quarters · filed 2017-11-08 | 99.41K shares 10-Q · filed 2017-11-08 | 106.16K shares derived: sum of 4 quarters · filed 2017-11-08 |
| 2017-06-30 | 2.34K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 44.56K shares 10-Q · filed 2017-08-09 | 51.31K shares derived: sum of 3 quarters · filed 2017-08-09 | 55.31K shares derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | 42.22K shares 10-Q · filed 2017-05-09 | 48.97K shares derived: sum of 2 quarters · filed 2017-05-09 | 52.97K shares derived: sum of 3 quarters · filed 2017-05-09 | 52.97K shares derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-31 | 6.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | 10.75K shares derived: sum of 2 quarters · filed 2017-03-07 | 10.75K shares derived: sum of 3 quarters · filed 2017-03-07 | 10.75K shares 10-K · filed 2017-03-07 |
| 2016-09-30 | 4.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 4.00K shares derived: sum of 2 quarters · filed 2016-11-14 | 4.00K shares 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2016-08-09 | 0.00 shares 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | 0.00 shares 10-Q/A · filed 2016-08-09 | |||
| 2015-12-31 | 140.12K shares 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |